[1] Achiwa, H., Yatabe, Y., Hida, T., Kuroishi, T., Kozaki, K., Nakamura, S., Ogawa, M., Sugiura, T., Mitsudomi, T., and Takahashi, T. (1999). Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res 5, 1001-1005 .10353732
[2] Alessi, D.R., Sakamoto, K., and Bayascas, J.R. (2006). LKB1-dependent signaling pathways. Annu Rev Biochem 75, 137-163 .16756488
[3] Alexander, A., Cai, S.L., Kim, J., Nanez, A., Sahin, M., MacLean, K.H., Inoki, K., Guan, K.L., Shen, J., Person, M.D., (2010). ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 107, 4153-4158 .20160076
[4] Avizienyte, E., Loukola, A., Roth, S., Hemminki, A., Tarkkanen, M., Salovaara, R., Arola, J., Bützow, R., Husgafvel-Pursiainen, K., Kokkola, A., (1999). LKB1 somatic mutations in sporadic tumors. Am J Pathol 154, 677-681 .10079245
[5] Baas, A.F., Kuipers, J., van der Wel, N.N., Batlle, E., Koerten, H.K., Peters, P.J., and Clevers, H.C. (2004). Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116, 457-466 .15016379
[6] Carretero, J., Medina, P.P., Blanco, R., Smit, L., Tang, M., Roncador, G., Maestre, L., Conde, E., Lopez-Rios, F., Clevers, H.C., (2007). Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer. Oncogene 26, 1616-1625 .16953221
[7] Carretero, J., Medina, P.P., Pio, R., Montuenga, L.M., and Sanchez-Cespedes, M. (2004). Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene. Oncogene 23, 4037-4040 .15021901
[8] Carretero, J., Shimamura, T., Rikova, K., Jackson, A.L., Wilkerson, M.D., Borgman, C.L., Buttarazzi, M.S., Sanofsky, B.A., McNamara, K.L., Brandstetter, K.A., (2010). Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell 17, 547-559 .20541700
[9] Contreras, C.M., Akbay, E.A., Gallardo, T.D., Haynie, J.M., Sharma, S., Tagao, O., Bardeesy, N., Takahashi, M., Settleman, J., Wong, K.K., (2008). Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy. Dis Models & Mechan 3, 181-193 .
[10] Contreras, C.M., Gurumurthy, S., Haynie, J.M., Shirley, L.J., Akbay, E.A., Wingo, S.N., Schorge, J.O., Broaddus, R.R., Wong, K.K., Bardeesy, N., (2008). Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas. Cancer Res 68, 759-766 .18245476
[11] Ding, L., Getz, G., Wheeler, D.A., Mardis, E.R., McLellan, M.D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D.M., Morgan, M.B., (2008). Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069-1075 .18948947
[12] Forcet, C., Etienne-Manneville, S., Gaude, H., Fournier, L., Debilly, S., Salmi, M., Baas, A., Olschwang, S., Clevers, H., and Billaud, M. (2005). Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity. Hum Mol Genet 14, 1283-1292 .15800014
[13] Gan, B., Hu, J., Jiang, S., Liu, Y., Sahin, E., Zhuang, L., Fletcher-Sananikone, E., Colla, S., Wang, Y.A., Chin, L., (2010). Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 468, 701-704 .21124456
[14] Gandhi, L., McNamara, K.L., Li, D., Borgman, C.L., McDermott, U., Brandstetter, K.A., Padera, R.F., Chirieac, L.R., Settleman, J.E., and Wong, K.K. (2009). Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis. Cancer Pre Res (Phila), Pa 2, 330-337 .
[15] Gao, B., Sun, Y., Zhang, J., Ren, Y., Fang, R., Han, X., Shen, L., Liu, X.Y., Pao, W., Chen, H., (2010a). Spectrum of LKB1, EGFR, and KRAS mutations in chinese lung adenocarcinomas. J Thorac Oncol 5, 1130-1135 .20559149
[16] Gao, Y., Xiao, Q., Ma, H., Li, L., Liu, J., Feng, Y., Fang, Z., Wu, J., Han, X., Zhang, J., (2010b). LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc Natl Acad Sci U S A 107, 18892-18897 .20956321
[17] Giardiello, F.M., Welsh, S.B., Hamilton, S.R., Offerhaus, G.J., Gittelsohn, A.M., Booker, S.V., Krush, A.J., Yardley, J.H., and Luk, G.D. (1987). Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316, 1511-1514 .3587280
[18] Gurumurthy, S., Xie, S.Z., Alagesan, B., Kim, J., Yusuf, R.Z., Saez, B., Tzatsos, A., Ozsolak, F., Milos, P., Ferrari, F., (2010). The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 468, 659-663 .21124451
[19] Hemminki, A. (1999). The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol Life Sci 55, 735-750 .10379360
[20] Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., H?glund, P., (1998). A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391, 184-187 .9428765
[21] Hezel, A.F., Gurumurthy, S., Granot, Z., Swisa, A., Chu, G.C., Bailey, G., Dor, Y., Bardeesy, N., and Depinho, R.A. (2008). Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol Cell Biol 28, 2414-2425 .18227155
[22] Huang, Q., Wu, Y.T., Tan, H.L., Ong, C.N., and Shen, H.M. (2009). A novel function of poly(ADP-ribose) polymerase-1 in modulation of autophagy and necrosis under oxidative stress. Cell Death Differ 16, 264-277 .18974775
[23] Inge, L.J., Coon, K.D., Smith, M.A., and Bremner, R.M. (2009). Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose. J Thorac Cardiovasc Surg 137, 580-586 .19258070
[24] Jackson, E.L., Willis, N., Mercer, K., Bronson, R.T., Crowley, D., Montoya, R., Jacks, T., and Tuveson, D.A. (2001). Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15, 3243-3248 .11751630
[25] Jenne, D.E., Reimann, H., Nezu, J., Friedel, W., Loff, S., Jeschke, R., Müller, O., Back, W., and Zimmer, M. (1998). Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18, 38-43 .9425897
[26] Ji, H., Ramsey, M.R., Hayes, D.N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M.C., Shimamura, T., Perera, S.A., (2007). LKB1 modulates lung cancer differentiation and metastasis. Nature 448, 807-810 .17676035
[27] Jimenez, A.I., Fernandez, P., Dominguez, O., Dopazo, A., and Sanchez-Cespedes, M. (2003). Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3′-phosphate kinase/PTEN pathway. Cancer Res 63, 1382-1388 .12649203
[28] Jones, R.G., Plas, D.R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M.J., and Thompson, C.B. (2005). AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18, 283-293 .15866171
[29] Karuman, P., Gozani, O., Odze, R.D., Zhou, X.C., Zhu, H., Shaw, R., Brien, T.P., Bozzuto, C.D., Ooi, D., Cantley, L.C., (2001). The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell 7, 1307-1319 .11430832
[30] Katajisto, P., Vallenius, T., Vaahtomeri, K., Ekman, N., Udd, L., Tiainen, M., and M?kel?, T.P. (2007). The LKB1 tumor suppressor kinase in human disease. Biochim Biophys Acta 1775, 63-75 .17010524
[31] Keith, B., and Simon, M.C. (2007). Hypoxia-inducible factors, stem cells, and cancer. Cell 129, 465-472 .17482542
[32] Kemphues, K.J., Priess, J.R., Morton, D.G., and Cheng, N.S. (1988). Identification of genes required for cytoplasmic localization in early C. elegans embryos. Cell 52, 311-320 .3345562
[33] Koivunen, J.P., Kim, J., Lee, J., Rogers, A.M., Park, J.O., Zhao, X., Naoki, K., Okamoto, I., Nakagawa, K., Yeap, B.Y., (2008). Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer 99, 245-252 .18594528
[34] Lee, J.H., Koh, H., Kim, M., Kim, Y., Lee, S.Y., Karess, R.E., Lee, S.H., Shong, M., Kim, J.M., Kim, J., (2007). Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 447, 1017-1020 .17486097
[35] Liang, J., Shao, S.H., Xu, Z.X., Hennessy, B., Ding, Z., Larrea, M., Kondo, S., Dumont, D.J., Gutterman, J.U., Walker, C.L., (2007). The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 9, 218-224 .17237771
[36] Mahoney, C.L., Choudhury, B., Davies, H., Edkins, S., Greenman, C., Haaften, G., Mironenko, T., Santarius, T., Stevens, C., Stratton, M.R., (2009). LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition. Br J Cancer 100, 370-375 .19165201
[37] Marignani, P.A., Kanai, F., and Carpenter, C.L. (2001). LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J Biol Chem 276, 32415-32418 .11445556
[38] Matsumoto, S., Iwakawa, R., Takahashi, K., Kohno, T., Nakanishi, Y., Matsuno, Y., Suzuki, K., Nakamoto, M., Shimizu, E., Minna, J.D., (2007). Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene 26, 5911-5918 .17384680
[39] McCarthy, A., Lord, C.J., Savage, K., Grigoriadis, A., Smith, D.P., Weigelt, B., Reis-Filho, J.S., and Ashworth, A. (2009). Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formation. J Pathol 219, 306-316 .19681070
[40] Memmott, R.M., Gills, J.J., Hollingshead, M., Powers, M.C., Chen, Z., Kemp, B., Kozikowski, A., and Dennis, P.A. (2008). Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells. Cancer Res 68, 580-588 .18199555
[41] Mita, M., Sankhala, K., Abdel-Karim, I., Mita, A., and Giles, F. (2008). Deforolimus (AP23573) a novel mTOR inhibitor in clinical development. Expert Opin Investig Drugs 17, 1947-1954 .19012509
[42] Miyoshi, H., Nakau, M., Ishikawa, T.O., Seldin, M.F., Oshima, M., and Taketo, M.M. (2002). Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res 62, 2261-2266 .11956081
[43] Moren, A., Raja, E., Heldin, C.H., and Moustakas, A. (2011). Negative regulation of TGF{beta} signaling by the kinase LKB1 and the scaffolding protein LIP1. J Biol Chem 286(1): 341-353 .
[44] Nakada, D., Saunders, T.L., and Morrison, S.J. (2010). Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468, 653-658 .21124450
[45] Nakau, M., Miyoshi, H., Seldin, M.F., Imamura, M., Oshima, M., and Taketo, M.M. (2002). Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res 62, 4549-4553 .12183403
[46] O’Neill, G.M., Seo, S., Serebriiskii, I.G., Lessin, S.R., and Golemis, E.A. (2007). A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9. Cancer Res 67, 8975-8979 .17908996
[47] Onozato, R., Kosaka, T., Achiwa, H., Kuwano, H., Takahashi, T., Yatabe, Y., and Mitsudomi, T. (2007). LKB1 gene mutations in Japanese lung cancer patients. Cancer Sci 98, 1747-1751 .17711506
[48] Rodriguez-Nieto, S., and Sanchez-Cespedes, M. (2009). BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer. Carcinogenesis 30, 547-554 .19176640
[49] Roy, B.C., Kohno, T., Iwakawa, R., Moriguchi, T., Kiyono, T., Morishita, K., Sanchez-Cespedes, M., Akiyama, T., and Yokota, J. (2010). Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells. Lung Cancer 70, 136-145 .20207041
[50] Sanchez-Cespedes, M. (2007). A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 26, 7825-7832 .17599048
[51] Sanchez-Cespedes, M., Parrella, P., Esteller, M., Nomoto, S., Trink, B., Engles, J.M., Westra, W.H., Herman, J.G., and Sidransky, D. (2002). Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 62, 3659-3662 .12097271
[52] Shackelford, D.B., and Shaw, R.J. (2009). The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9, 563-575 .19629071
[53] Shaw, R.J., Kosmatka, M., Bardeesy, N., Hurley, R.L., Witters, L.A., DePinho, R.A., and Cantley, L.C. (2004). The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 101, 3329-3335 .14985505
[54] Sobottka, S.B., Haase, M., Fitze, G., Hahn, M., Schackert, H.K., and Schackert, G. (2000). Frequent loss of heterozygosity at the 19p13.3 locus without LKB1/STK11 mutations in human carcinoma metastases to the brain. J Neurooncol 49, 187-195 .11212897
[55] Spano, J.P., Chouahnia, K., and Morere, J.F. (2004). Cyclooxygenase 2 inhibitors and lung carcinoma. Bull Cancer 91(Suppl 2), S109-S112 .
[56] Sun, Y., Ren, Y., Fang, Z., Li, C., Fang, R., Gao, B., Han, X., Tian, W., Pao, W., Chen, H., (2010). Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases. J Clin Oncol 28, 4616-4620 .20855837
[57] Tomlinson, I.P., and Houlston, R.S. (1997). Peutz-Jeghers syndrome. J Med Genet 34, 1007-1011 .9429144
[58] Upadhyay, S., Liu, C., Chatterjee, A., Hoque, M.O., Kim, M.S., Engles, J., Westra, W., Trink, B., Ratovitski, E., and Sidransky, D. (2006). LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer. Cancer Res 66, 7870-7879 .16912160
[59] Weir, B.A., Woo, M.S., Getz, G., Perner, S., Ding, L., Beroukhim, R., Lin, W.M., Province, M.A., Kraja, A., Johnson, L.A., (2007). Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893-898 .17982442
[60] Wingo, S.N., Gallardo, T.D., Akbay, E.A., Liang, M.C., Contreras, C.M., Boren, T., Shimamura, T., Miller, D.S., Sharpless, N.E., Bardeesy, N., (2009). Somatic LKB1 mutations promote cervical cancer progression. PLoS One 4, e5137.19340305
[61] Wu, Y., and Zhou, B.P. (2008). New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai) 40, 643-650 .18604456
[62] Zeng, P.Y., and Berger, S.L. (2006). LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation. Cancer Res 66, 10701-10708 .17108107
[63] Zhang, S., Schafer-Hales, K., Khuri, F.R., Zhou, W., Vertino, P.M., and Marcus, A.I. (2008). The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity. Cancer Res 68, 740-748 .18245474
